Calls Purchased on ARIAD Pharmaceuticals (ARIA)

Shares of ARIAD Pharmaceuticals ARIA are higher on the session by 3.37%, currently trading at $9.50. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A short while ago the June 2011 $11.00 call was purchased 1,600 times, on the offer, on open interest of only 10 contracts. This signals new positioning on the strike. Overall call volume is now running at 2.40x the daily average with 82% of all calls traded being purchases on the offer. ARIAD Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of drugs to provide therapeutic intervention in treating human diseases at the cellular level.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: OptionsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!